191 related articles for article (PubMed ID: 15057286)
1. Tracing the network connecting BRCA and Fanconi anaemia proteins.
Venkitaraman AR
Nat Rev Cancer; 2004 Apr; 4(4):266-76. PubMed ID: 15057286
[No Abstract] [Full Text] [Related]
2. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
Wang W
Nat Rev Genet; 2007 Oct; 8(10):735-48. PubMed ID: 17768402
[TBL] [Abstract][Full Text] [Related]
3. New complexities for BRCA1 and BRCA2.
Kerr P; Ashworth A
Curr Biol; 2001 Aug; 11(16):R668-76. PubMed ID: 11525763
[TBL] [Abstract][Full Text] [Related]
4. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
5. Biomedicine. D-Day for BRCA2.
Witt E; Ashworth A
Science; 2002 Jul; 297(5581):534. PubMed ID: 12065747
[No Abstract] [Full Text] [Related]
6. Exploring the link between MORF4L1 and risk of breast cancer.
Martrat G; Maxwell CM; Tominaga E; Porta-de-la-Riva M; Bonifaci N; Gómez-Baldó L; Bogliolo M; Lázaro C; Blanco I; Brunet J; Aguilar H; Fernández-Rodríguez J; Seal S; Renwick A; Rahman N; Kühl J; Neveling K; Schindler D; Ramírez MJ; Castellà M; Hernández G; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Davidson R; Ong KR; Cook J; Douglas F; Hodgson S; Brewer C; Morrison PJ; Porteous M; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Pasini B; Ottini L; Putignano AL; Savarese A; Bernard L; Radice P; Healey S; Spurdle A; Chen X; Beesley J; ; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Asperen CJ; Bodmer D; Ausems MG; van Os TA; Blok MJ; Meijers-Heijboer HE; Hogervorst FB; ; Goldgar DE; Buys S; John EM; Miron A; Southey M; Daly MB; ; ; Harbst K; Borg A; Rantala J; Barbany-Bustinza G; Ehrencrona H; Stenmark-Askmalm M; Kaufman B; Laitman Y; Milgrom R; Friedman E; Domchek SM; Nathanson KL; Rebbeck TR; Johannsson OT; Couch FJ; Wang X; Fredericksen Z; Cuadras D; Moreno V; Pientka FK; Depping R; Caldés T; Osorio A; Benítez J; Bueren J; Heikkinen T; Nevanlinna H; Hamann U; Torres D; Caligo MA; Godwin AK; Imyanitov EN; Janavicius R; ; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Verny-Pierre C; Castera L; de Pauw A; Bignon YJ; Uhrhammer N; Peyrat JP; Vennin P; Ferrer SF; Collonge-Rame MA; Mortemousque I; McGuffog L; Chenevix-Trench G; Pereira-Smith OM; Antoniou AC; Cerón J; Tominaga K; Surrallés J; Pujana MA
Breast Cancer Res; 2011 Apr; 13(2):R40. PubMed ID: 21466675
[TBL] [Abstract][Full Text] [Related]
7. A growing network of cancer-susceptibility genes.
Venkitaraman AR
N Engl J Med; 2003 May; 348(19):1917-9. PubMed ID: 12736286
[No Abstract] [Full Text] [Related]
8. Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.
Ameziane N; van den Ouweland AM; Adank MA; Vijzelaar RN; Errami A; Dorsman JC; Joenje H; Meijers-Heijboer H; Waisfisz Q
Breast Cancer Res Treat; 2009 Dec; 118(3):651-3. PubMed ID: 19504183
[No Abstract] [Full Text] [Related]
9. [Fanconi anemia and DNA-damage response network].
Matsushita N; Kitao H; Ishiai M; Takata M
Tanpakushitsu Kakusan Koso; 2009 Mar; 54(4 Suppl):580-5. PubMed ID: 21089513
[No Abstract] [Full Text] [Related]
10. The twists and turns in BRCA's path.
Couzin J
Science; 2003 Oct; 302(5645):591-3. PubMed ID: 14576418
[No Abstract] [Full Text] [Related]
11. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
12. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.
Lok BH; Carley AC; Tchang B; Powell SN
Oncogene; 2013 Jul; 32(30):3552-8. PubMed ID: 22964643
[TBL] [Abstract][Full Text] [Related]
13. Connecting Fanconi anemia to BRCA1.
Joenje H; Arwert F
Nat Med; 2001 Apr; 7(4):406-7. PubMed ID: 11283658
[No Abstract] [Full Text] [Related]
14. The Fanconi anaemia genome stability and tumour suppressor network.
Bogliolo M; Cabré O; Callén E; Castillo V; Creus A; Marcos R; Surrallés J
Mutagenesis; 2002 Nov; 17(6):529-38. PubMed ID: 12435850
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer and Fanconi anemia: what are the connections?
Zdzienicka MZ; Arwert F
Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
[TBL] [Abstract][Full Text] [Related]
17. Homologous repair of DNA damage and tumorigenesis: the BRCA connection.
Jasin M
Oncogene; 2002 Dec; 21(58):8981-93. PubMed ID: 12483514
[TBL] [Abstract][Full Text] [Related]
18. Involvement of homologous recombination in carcinogenesis.
Reliene R; Bishop AJ; Schiestl RH
Adv Genet; 2007; 58():67-87. PubMed ID: 17452246
[TBL] [Abstract][Full Text] [Related]
19. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
20. Genetically determined subdivision of human populations with respect to the risk of breast cancer in women.
Tarasov VA; Aslanyan MM; Tsyrendorzhiyeva ES; Litvinov SS; Gar'kavtseva RF; Altukhov YP
Dokl Biol Sci; 2006; 406():66-9. PubMed ID: 16572816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
